e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

17.49 -0.57 (-3.16%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nurix Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 Next >

Unveiling 6 Analyst Insights On Nurix Therapeutics ↗

October 11, 2024

Via Benzinga

This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

October 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 10, 2024

Via Benzinga

Analyst Ratings For Nurix Therapeutics ↗

September 04, 2024

Via Benzinga

Nvidia’s Earnings Loom In The Summer Stock Snooze-Fest ↗

August 27, 2024

To the casual observer, stocks look to be drifting around on a Lazy River ride, but the truth is, they’re consolidating their recent gains. This is actually bullish price action.

Via Talk Markets

Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics ↗

July 31, 2024

Via Benzinga

Analyst Scoreboard: 12 Ratings For Nurix Therapeutics ↗

July 15, 2024

Via Benzinga

Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts ↗

June 27, 2024

Via Benzinga

TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

August 14, 2024

Via Benzinga

Here Is What You Missed On Wall Street On Friday ↗

July 14, 2024

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

Via Talk Markets

Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance ↗

June 21, 2024

The Nasdaq and S&P 500 backed off highs. The Dow regained a key level.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

June 18, 2024

Via Benzinga

Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights ↗

June 05, 2024

Via Benzinga

Key Takeaways From Nurix Therapeutics Analyst Ratings ↗

May 14, 2024

Via Benzinga

Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know ↗

April 02, 2024

Via Benzinga

What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? ↗

June 17, 2024

Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for...

Via Benzinga

Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

June 17, 2024

Via Benzinga

Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial ↗

June 17, 2024

San Francisco-based Nurix Therapeutics reported robust results in an ongoing treatment against a stubborn form of leukemia.

Via Investor's Business Daily

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 17, 2024

We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!

Via InvestorPlace

Analyst Scoreboard: 7 Ratings For Nurix Therapeutics ↗

March 11, 2024

Via Benzinga

Decoding 4 Analyst Evaluations For Nurix Therapeutics ↗

February 16, 2024

Via Benzinga

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 12, 2024

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Via Benzinga

Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 12, 2024

U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday.

Via Benzinga

Topics Stocks

Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗

April 12, 2024

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 11, 2024

Via Benzinga

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 11, 2024

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Via Benzinga

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 11, 2024

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.

Via Benzinga

Topics Stocks

NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗

April 10, 2024

NRIX stock results show that Nurix Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 09, 2024

Via Benzinga

BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday ↗

April 09, 2024

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy